ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
IMMUTEP ORD
$0.070
$0.004 (5.41%)
Day Range
$0.070 - $0.072
52 Week Range
$0.028 - $0.470
Volume
48.53M
Avg Volume (10D)
96.44M
Market Cap
$103.16M
Price Chart
Market Statistics
Open$0.072
Previous Close$0.074
Day High$0.072
Day Low$0.070
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap103.16M
Shares Outstanding1.47B
Price to Book1.10
Trading Activity
Volume48.53M
Value Traded3.44M
Bid$0.070 × 395,062
Ask$0.071 × 700,000
Performance
1 Day1.37%
5 Day2.78%
13 Week-81.95%
52 Week-69.80%
YTD-82.17%
Technical Indicators
RSI (14)37.13
50-Day SMA$0.191
200-Day SMA$0.275
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
3 min read
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]
2 min read
